Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01606826 · ClinicalTrials.gov registry record
Severe Asthma Research Program
A clinical trial of Asthma, sponsored by Milton S. Hershey Medical Center.
- Active
- Registry status
- 1,100
- Enrollment target
- 8
- Study locations
NCT01606826 is a study of Asthma that is active but no longer recruiting, run by Milton S. Hershey Medical Center. The registered enrollment target is 1,100 participants, below the 1,560-participant average among 374 other Asthma trials with a reported enrollment target (29% lower). The trial reports 8 study locations across 7 states.
The verdict
NCT01606826, a study of Asthma, is active but no longer recruiting, sponsored by Milton S. Hershey Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 1,100 participants
- Enrollment target
- 8
- Study locations
Study Summary
The mission of the SARP is to improve the understanding of severe asthma through integrated study of its clinical and biological features and to evaluate their changes over time. The ultimate goal of these efforts is to promote better treatments for severe asthma.
Conditions Studied
Study Locations (8)
Massachusetts
- Brigham & Women's Hospital - Boston
- Children's Hospital, Boston - Boston
California
- University of California, San Francisco - San Francisco
Missouri
- Washington University - St Louis
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Ohio
- Cleveland Clinic - Cleveland
Pennsylvania
- University of Pittsburgh - Pittsburgh
Wisconsin
- University of Wisconsin-Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,100 participants |
| Start Date | 2012-10 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01606826
The ClinicalTrials.gov registry entry for NCT01606826 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,560-participant average among 374 other Asthma trials with a reported enrollment target (29% lower). The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 0 interventions.
NCT01606826 reports 8 study locations spanning 7 distinct geographic areas - top geographies include Massachusetts, California, Missouri.
Frequently Asked Questions
What is clinical trial NCT01606826 about?
NCT01606826 is a clinical study titled "Severe Asthma Research Program". The mission of the SARP is to improve the understanding of severe asthma through integrated study of its clinical and biological features and to evaluate their changes over time. The ultimate goal of these efforts is to promote better treatments for severe asthma.
What is the current status of trial NCT01606826?
This trial is currently active not recruiting. The enrollment target is 1,100 participants. The study started on 2012-10. Estimated completion is 2026-12-31.
What conditions does trial NCT01606826 study?
This clinical trial studies the following conditions: Asthma.
Who is sponsoring clinical trial NCT01606826?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01606826 being conducted?
This trial has 8 study locations across California, Massachusetts, Missouri, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.